Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., February 14, 2025, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31, 2024 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results, along with Limited Review Report' for the quarter and nine months ended on December 31, 2024 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 12:30 PM and concluded at 12:50 PM.

pdf

Medico Intercontinental Ltd.

06 Feb 2025

38.97

2.71%

Board Meeting

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Compliance Of Regulation 29, 30 And …

BSE India

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter and nine months ended 31st December, 2024 and any other business items as per agenda circulated.

pdf

Medico Intercontinental Ltd.

03 Jan 2025

38.97

2.71%

Company Update

Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Confirmation Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December, 2024.

pdf

Is Medico Intercontinental Ltd. worth buying?

33 Votes:

Buy 75.76%

Sell 12.12%

Hold 12.12%